Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000144·Dyne Therapeutics, Inc.
Schedule 13G ownership disclosure
Dyne Therapeutics Inc
Common Stock · CUSIP: 26818M108
Event date: 2025-03-31
- Filing-level shares
- 10,353,875
- Percent of class
- 9.2%
- JANUS HENDERSON GROUP PLC
Shares: 10,353,875 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000144
- Form type
- SCHEDULE 13G/A
- Filer
- Dyne Therapeutics, Inc.
- CIK
- CIK 1818794
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership